172 related articles for article (PubMed ID: 35643168)
1. Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study.
Tomkins-Netzer O; Sar S; Barnett-Griness O; Friedman B; Shyriaieva H; Saliba W
Ophthalmology; 2022 Oct; 129(10):1087-1095. PubMed ID: 35643168
[TBL] [Abstract][Full Text] [Related]
2. Association Between the BNT162b2 Messenger RNA COVID-19 Vaccine and the Risk of Sudden Sensorineural Hearing Loss.
Yanir Y; Doweck I; Shibli R; Najjar-Debbiny R; Saliba W
JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):299-306. PubMed ID: 35201275
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
[TBL] [Abstract][Full Text] [Related]
4. Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database.
Kumar A; Miller DC; Sun Y; Arnold BF; Acharya NR
Ophthalmology; 2023 Dec; 130(12):1269-1278. PubMed ID: 37480943
[TBL] [Abstract][Full Text] [Related]
5. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
6. Noninfectious Uveitis Risk After COVID-19 Vaccination: A Nationwide Retrospective Cohort Study.
Chang MS; Kim HR; Kim S; Lee CS; Byeon SH; Kim SS; Lee SW; Kim YJ
Am J Ophthalmol; 2024 Feb; 258():22-31. PubMed ID: 37739204
[TBL] [Abstract][Full Text] [Related]
7. Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.
Sun Y; Miller DC; Akpandak I; Chen EM; Arnold BF; Acharya NR
Ophthalmology; 2022 Oct; 129(10):1096-1106. PubMed ID: 35588945
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
10. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
11. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand.
Walton M; Pletzer V; Teunissen T; Lumley T; Hanlon T
Drug Saf; 2023 Sep; 46(9):867-879. PubMed ID: 37556109
[TBL] [Abstract][Full Text] [Related]
12. Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study.
Shibli R; Barnett O; Abu-Full Z; Gronich N; Najjar-Debbiny R; Doweck I; Rennert G; Saliba W
Lancet Reg Health Eur; 2021 Dec; 11():100236. PubMed ID: 34751262
[TBL] [Abstract][Full Text] [Related]
13. The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data.
Miller DC; Sun Y; Chen EM; Arnold BF; Acharya NR
Ophthalmology; 2022 Mar; 129(3):334-343. PubMed ID: 34648828
[TBL] [Abstract][Full Text] [Related]
14. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
[No Abstract] [Full Text] [Related]
15. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
[TBL] [Abstract][Full Text] [Related]
16. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients.
Wong CKH; Lui DTW; Xiong X; Chui CSL; Lai FTT; Li X; Wan EYF; Cheung CL; Lee CH; Woo YC; Au ICH; Chung MSH; Cheng FWT; Tan KCB; Wong ICK
BMC Med; 2022 Oct; 20(1):339. PubMed ID: 36229814
[TBL] [Abstract][Full Text] [Related]
17. A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y; Hasegawa E; Keino H; Usui Y; Maruyama K; Yamamoto Y; Kaburaki T; Iwata D; Takeuchi M; Kusuhara S; Takase H; Nagata K; Yanai R; Kaneko Y; Iwahashi C; Fukushima A; Ohguro N; Sonoda KH;
Jpn J Ophthalmol; 2023 Jan; 67(1):14-21. PubMed ID: 36417027
[TBL] [Abstract][Full Text] [Related]
18. Navigating Coronavirus Disease 2019 Vaccination and Uveitis: Identifying the Rates and Risk of Recurrent Uveitis after Coronavirus Disease Vaccination.
Jordan CA; Townend S; Allen N; Sims J; McGhee CNJ; Niederer RL
Ophthalmology; 2023 May; 130(5):501-508. PubMed ID: 36538991
[TBL] [Abstract][Full Text] [Related]
19. Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination: Matched Cohort and Self-Controlled Case Series Studies Using a Large Database.
Hashimoto Y; Yamana H; Iwagami M; Ono S; Takeuchi Y; Michihata N; Uemura K; Yasunaga H; Aihara M; Kaburaki T
Ophthalmology; 2023 Mar; 130(3):256-264. PubMed ID: 36306975
[TBL] [Abstract][Full Text] [Related]
20. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
